Schedule 13G ownership disclosure

KITE PHARMA INC COM

Security class unavailable · CUSIP: 49803L109

Event date: 2015-09-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,688,738
Percent of class
6.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001103804-15-000052
Form type
SC 13G
Filer
Kite Pharma, Inc.
CIK
CIK 1510580
Filed
Oct 05, 2015
Reporting period
Sep 25, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub